ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-Analysis
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-2169
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2011
Authors
Publisher
American Association for Cancer Research (AACR)